GHK-Cu Dosage Calculator for Skin & Tissue Repair
Calculate GHK-Cu copper peptide injection dosage protocols, reconstitution volume, and syringe draw units based on commonly discussed clinician-guided ranges. This calculator performs math conversions only — it does not recommend doses for unsupervised use.
Copper Peptide Protocol Planner
Select your protocol approach and goal to see common GHK-Cu dosing patterns discussed in clinician-guided settings. These are math conversions only, not medical recommendations.
GHK-Cu Common Research & Clinician-Guided Ranges
| Approach | Amount | Frequency | Cycle | Use Case |
|---|---|---|---|---|
| Conservative starting | 0.5-1 mg | Once daily | Defined on/off | First-time, gradual introduction |
| Standard escalation | 1 mg → 2 mg | Once daily | 30 days on, 30 off | Skin quality, healthy aging |
| Steady daily | 1-2 mg | Once daily | Defined on/off | Returning patients, consistent dose |
| Higher-intensity | 2-3 mg | Once daily | Short defined cycle | Tissue-repair, connective-tissue |
Standard 30-Day Escalation Schedule
| Days | Daily Dose | Phase |
|---|---|---|
| 1-15 | 1 mg once daily | Active (low) |
| 16-30 | 2 mg once daily | Active (stepped up) |
| 31-60 | Rest period | Off-cycle reassessment |
Important Notes
- GHK-Cu is a copper-binding tripeptide (glycyl-L-histidyl-L-lysine) associated with skin renewal, collagen support, and tissue remodeling
- Common administration: subcutaneous injection, once daily
- Typical cycle: 30 days active, 30 days rest — allows provider to reassess before continuing
- Copper component matters — GHK-Cu is a signaling peptide, not a "more is better" compound
- Often discussed alongside BPC-157 and TB-500 in tissue-repair contexts (pubmed.ncbi.nlm.nih.gov)
- Possible side effects: injection-site reactions, copper-related sensitivity, fatigue
- Do not use if: pregnant, breastfeeding, have Wilson's disease or copper storage disorder, or without clinician supervision
- This calculator performs math conversions only — it does not verify product quality, safety, or medical appropriateness
Reconstitution Calculator
Calculate how much bacteriostatic water to add and how many units to draw on your syringe for your GHK-Cu dose.
Enter values and click Calculate
How Reconstitution Works
- Determine concentration: Divide peptide amount by water volume (e.g., 50 mg ÷ 2 mL = 25 mg/mL)
- Calculate draw volume: Divide your dose by concentration (e.g., 1 mg ÷ 25 mg/mL = 0.04 mL)
- Convert to syringe units: Multiply mL by 100 for U-100 syringes (0.04 mL = 4U)
- Verify syringe capacity: Ensure the draw volume fits your syringe
Example Calculation
Vial: 50 mg GHK-Cu
Water: 2 mL bacteriostatic
Dose: 1 mg
Syringe: 100U (1 mL)
Concentration: 50 mg ÷ 2 mL = 25 mg/mL
Draw volume: 1 mg ÷ 25 mg/mL = 0.04 mL = 4U on a U-100 syringe
Doses per vial: 50 mg ÷ 1 mg = 50 doses
Escalation Protocol Example
Vial: 50 mg GHK-Cu
Water: 2 mL bacteriostatic → 25 mg/mL
Days 1-15: 1 mg daily = 0.04 mL = 4U → 15 doses used
Days 16-30: 2 mg daily = 0.08 mL = 8U → 30 doses used
Total: 45 mg used out of 50 mg vial (15 doses × 1 mg + 15 doses × 2 mg)
GHK-Cu Dosage Calculator
If you are searching for a GHK-Cu dosage calculator, you may be trying to organize copper peptide injection information into a clear plan. Start here: no online calculator can make self-directed GHK-Cu use safe or medically right. This tool performs math conversions and organizes commonly discussed clinician-guided protocol patterns — it does not provide a personal dosing recommendation.
What GHK-Cu dosing ranges are commonly discussed?
The most commonly referenced ghk-cu peptide injection dosage range is 0.5 mg to 3 mg daily, administered subcutaneously. A frequently cited schedule uses 1 mg daily for days 1-15, then 2 mg daily for days 16-30, followed by a 30-day rest period. These ranges come from provider-directed content, not from large-scale human clinical trials. (bhrcenter.com)
How the protocol approaches differ
The ghk-cu dosage chart in this calculator reflects four common approaches:
- Conservative starting (0.5-1 mg): For first-time users in a supervised setting. Gives the provider room to assess response before increasing.
- Standard 30-day escalation (1→2 mg): The most commonly cited schedule. 1 mg for days 1-15, 2 mg for days 16-30, then 30 days off.
- Steady daily (1-2 mg): For returning patients whose clinician prefers a consistent dose without mid-cycle increase.
- Higher-intensity supervised (2-3 mg): For focused tissue-repair or connective-tissue support under closer medical oversight.
Why cycling matters for GHK-Cu
Many ghkcu dosage plans use a 30-day active phase followed by a 30-day rest period. Cycling allows the provider to reassess goals, timing, and overall protocol before continuing. It also prevents the "more is better" mindset that can lead to unnecessary escalation without evidence of added benefit.
GHK-Cu alongside other peptides
GHK-Cu is often discussed alongside BPC-157 and TB-500 in tissue-repair contexts. BPC-157 is commonly discussed for tendon, ligament, and soft-tissue models, while TB-500 is linked to thymosin beta-4 pathways. GHK-Cu brings a different emphasis: skin quality, copper-peptide signaling, and collagen support. When a clinician combines peptides, the goal is to match complementary mechanisms to a specific outcome — not simply to add more compounds. (pubmed.ncbi.nlm.nih.gov)
How to evaluate GHK-Cu dosing claims
Before trusting any ghk-cu peptide dosing source, ask:
- Does it distinguish clinician-guided protocols from self-administration advice?
- Does it explain dose, frequency, cycle length, and rest period?
- Does it acknowledge that dosing should be individualized?
- Does it mention copper-related safety considerations?
- Does it recommend medical oversight rather than self-experimentation?
If a source skips these questions and jumps straight to dosing, treat it as a red flag.
The bottom line
A ghk-cu dosage calculator can help you understand the language around 0.5 mg, 1 mg, 2 mg, and 3 mg dosing, but it should not be treated as a self-treatment plan. The most commonly discussed range is 0.5-3 mg daily with 30-day cycling. Bring the chart-style information to a qualified clinician and ask: What dose fits my goal? How long is the active cycle? When do we reassess? That is a far safer way to use a ghk cu peptide dosing chart — as a conversation tool, not a shortcut.